Health Equity

The Coffee Bean & Tea Leaf Singapore debuts 'Mixers,' a line of vibrant, non-alcoholic drinks designed for social media and a new generation of consumers.

With new leaders from Cigna and Elevance, the firm is scaling its unique model for seniors in affordable housing amid a complex regulatory landscape.

Millions of Americans focus on diet and exercise for longevity, but new research reveals a shocking oversight. Is ignoring our hearing our biggest health mistake?

A new collaboration between the digital health giant and a top cancer center aims to deliver expert insights to doctors worldwide, tackling a complex field.

A new Medicare policy aims to cut costs on medical supplies, but patient advocates warn it could endanger millions by restricting access to essential care.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Williams Lake First Nation uncovers hazardous materials at a former residential school, calling for government funds to turn a site of trauma into one of healing.

From a 2024 startup to a global leader, see how Ascent Strategy Group used AI, cinematic storytelling, and a health equity mission to redefine the industry.

For a teen with rare genetic conditions, a sunken chest was a daily struggle. A pioneering surgery didn't just fix it—it gave him a new life.

Health AI firm Vi secures unicorn status with a $145M deal while launching new AI agents. But can its vision of 'health abundance' overcome ethical hurdles?

The AMA appoints Dr. John Wigneswaran, a physician-exec from Walmart and UnitedHealth, signaling a strategic shift toward corporate-style operations.

Amplexd Therapeutics launches a Phase 2 trial in Hong Kong for a novel, non-surgical HPV therapy, offering hope to millions in diagnostic limbo.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

Beyond the call bell, integrated systems are the new nervous system of modern hospitals, boosting patient safety, staff efficiency, and overall care.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

SERB Pharma's acquisition of Idefirix® rights offers new hope to thousands of highly sensitized patients previously unable to receive a kidney transplant.

Mineralys Therapeutics' lorundrostat shows promise for millions with uncontrolled blood pressure and kidney disease, targeting a key hormonal driver.

A new scholarship champions empathy in medicine, founded by a doctor whose own license has recently come under emergency suspension by state regulators.

Kidney care giant DaVita unveils ambitious 2030 targets for transplants, health equity, and sustainability, raising the bar for the healthcare industry.

A strategic investment from Olayan Financing Company positions MS Pharma to dominate the MENA biologics market, fueling Saudi Arabia's Vision 2030 goals.